ArticleJournal of inflammation research2025
Spermidine Exerts Neuroprotective Effects Following Intracerebral Hemorrhage in Mice Through Anti-Inflammation and Blood-Brain Barrier Protection.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Intracerebral hemorrhage (ICH) is a life-threatening subtype of stroke, and neuroinflammation is a key factor in brain injury after ICH. Spermidine (SPD), a natural polyamine existing in all eukaryotic cells, has exerted beneficial effects such as anti-inflammation and anti-oxidation in many disease models. However, its effects and mechanisms in ICH remain unclear. This study aims to investigate the therapeutic potential of SPD in the ICH model. Methods and Materials: In the in vivo experiments, C57BL/6 mice were randomly divided into three groups (Sham group, ICH + vehicle group, and ICH + SPD group). ICH was induced by collagenase VII and SPD (15 mg/kg) was administered intraperitoneally at 6, 30, and 54 hours post-ICH. Then the mice were euthanized on the third day for further experiments: Western blot, immunofluorescence staining, immunohistochemical staining, Evans blue extravasation, TUNEL staining, brain water content measurement and behavioral tests. In in vitro experiments, BV2 cells were stimulated with hemin for 24 hours to mimic ICH. Western blot and ELISA were used to assess inflammatory response of microglia. Results: The results of animal experiments showed that SPD dramatically reduced hematoma volume, area of brain injury, brain cell death, and significantly improved neurological deficits compared with the ICH + vehicle group. Furthermore, SPD suppressed the activated microglia/macrophages, infiltrated neutrophils and the expression of inflammatory cytokines (IL-1β, IL-6, and TNF-α), alleviated blood-brain barrier (BBB) damage, and reduced brain water content in vivo. In cell experiments, the results indicated that SPD (8 μM/L) suppressed the expression of CD32 and iNOS and the release of inflammatory factors (IL-1β, IL-6, and TNF-α). Conclusion: These findings indicate the neuroprotective role of SPD in the ICH model in mice, which is likely to be associated with inhibition of neuroinflammation and protection of the BBB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.